<DOC>
	<DOCNO>NCT00201955</DOCNO>
	<brief_summary>The purpose study determine potential safety effectiveness rebamipide eye drop , investigational eye drop develop treatment keratoconjunctivitis sicca ( dry eye ) .</brief_summary>
	<brief_title>Study Rebamipide Eye Drops Treat Dry Eye</brief_title>
	<detailed_description>There need effective therapy dry eye treat underlie cause syndrome . The goal study assess impact rebamipide dry eye symptom .</detailed_description>
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<criteria>must symptoms dry eye minimum 6 month must able sign date inform consent presence anterior segment disease glaucoma ocular hypertension use Restasis use topically instill ocular medication study use contact lenses history ocular surgery within 12 month female pregnant , breast feeding , childbearing potential willing remain abstinent use contraception presence StevensJohnson syndrome anticipate change medication throughout study concurrent involvement another study previous receipt drug safely wean ocular medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>dry eye</keyword>
	<keyword>keratoconjunctivitis sicca</keyword>
</DOC>